JP2013528577A5 - - Google Patents

Download PDF

Info

Publication number
JP2013528577A5
JP2013528577A5 JP2013506566A JP2013506566A JP2013528577A5 JP 2013528577 A5 JP2013528577 A5 JP 2013528577A5 JP 2013506566 A JP2013506566 A JP 2013506566A JP 2013506566 A JP2013506566 A JP 2013506566A JP 2013528577 A5 JP2013528577 A5 JP 2013528577A5
Authority
JP
Japan
Prior art keywords
water
fluorobenzyloxy
benzylamino
crystallization
propanamide methanesulfonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013506566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013528577A (ja
JP5808392B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/055309 external-priority patent/WO2011134763A1/en
Publication of JP2013528577A publication Critical patent/JP2013528577A/ja
Publication of JP2013528577A5 publication Critical patent/JP2013528577A5/ja
Application granted granted Critical
Publication of JP5808392B2 publication Critical patent/JP5808392B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013506566A 2010-04-27 2011-04-06 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法 Active JP5808392B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10161207.5 2010-04-27
EP10161207 2010-04-27
PCT/EP2011/055309 WO2011134763A1 (en) 2010-04-27 2011-04-06 Process for the production of ralfinamide methanesulfonate salts or their r-enantiomers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015104930A Division JP6345154B2 (ja) 2010-04-27 2015-05-22 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法

Publications (3)

Publication Number Publication Date
JP2013528577A JP2013528577A (ja) 2013-07-11
JP2013528577A5 true JP2013528577A5 (enExample) 2015-03-05
JP5808392B2 JP5808392B2 (ja) 2015-11-10

Family

ID=42634917

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013506566A Active JP5808392B2 (ja) 2010-04-27 2011-04-06 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法
JP2015104930A Active JP6345154B2 (ja) 2010-04-27 2015-05-22 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法
JP2017106571A Active JP6450420B2 (ja) 2010-04-27 2017-05-30 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015104930A Active JP6345154B2 (ja) 2010-04-27 2015-05-22 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法
JP2017106571A Active JP6450420B2 (ja) 2010-04-27 2017-05-30 ラルフィナミドメタンスルホネート塩またはそのr−エナンチオマーの製造方法

Country Status (27)

Country Link
US (2) US9505708B2 (enExample)
EP (1) EP2563355B1 (enExample)
JP (3) JP5808392B2 (enExample)
KR (1) KR101851118B1 (enExample)
CN (2) CN105037188B (enExample)
AR (1) AR085171A1 (enExample)
AU (1) AU2011246707B2 (enExample)
BR (1) BR112012027623B1 (enExample)
CA (1) CA2794389C (enExample)
CY (1) CY1117879T1 (enExample)
DK (1) DK2563355T3 (enExample)
EA (1) EA021389B1 (enExample)
ES (1) ES2590128T3 (enExample)
HR (1) HRP20161077T1 (enExample)
HU (1) HUE030504T2 (enExample)
IL (1) IL222532A (enExample)
LT (1) LT2563355T (enExample)
ME (1) ME02509B (enExample)
MX (1) MX342697B (enExample)
NZ (2) NZ602648A (enExample)
PL (1) PL2563355T3 (enExample)
PT (1) PT2563355T (enExample)
RS (1) RS55084B1 (enExample)
SI (1) SI2563355T1 (enExample)
SM (1) SMT201600266B (enExample)
TW (1) TWI492919B (enExample)
WO (1) WO2011134763A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2794389C (en) * 2010-04-27 2016-08-23 Newron Pharmaceuticals S.P.A. Process for the production of ralfinamide methanesulfonate salts or their r-enantiomers
CN103804341B (zh) * 2012-11-13 2018-04-10 中国人民解放军军事医学科学院毒物药物研究所 酰胺衍生物及其医药用途
CN104761531B (zh) * 2014-01-03 2017-12-01 中国人民解放军军事医学科学院毒物药物研究所 镇痛活性化合物及其医药用途
CN104292128A (zh) * 2014-07-01 2015-01-21 南京正科制药有限公司 一种沙芬酰胺晶型a
CN115368310B (zh) 2021-05-18 2025-06-27 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94466A (en) 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
GB9515412D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
PT1423168E (pt) 2001-09-03 2006-05-31 Newron Pharm Spa Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
EP1438956A1 (en) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
EP1596844A2 (en) * 2003-01-30 2005-11-23 Dynogen Pharmaceuticals Inc. Use of sodium channel modulators for treating gastrointestinal tract disorders
AR044007A1 (es) 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
US20070276046A1 (en) 2003-08-25 2007-11-29 Patricia Salvati Alpha-Aminoamide Derivatives Useful as Anti-Inflammatory Agents
EP1557166A1 (en) 2004-01-21 2005-07-27 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
EP1588704A1 (en) 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
DK1809271T5 (da) 2004-09-10 2010-12-06 Newron Pharm Spa Anvendelse af (R)-(halogenbenzyloxy)benzylaminopropanamider som natrium- og/eller calciumkanalselektive modulatorer
EP1870097A1 (en) 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
EP2029524B1 (en) * 2006-06-19 2014-11-26 Newron Pharmaceuticals S.p.A. Process for the production of 2- [4 - ( 3- and 2-fluorobenzyloxy) benzylamino] propan amides
JP5315674B2 (ja) * 2007-11-19 2013-10-16 セントラル硝子株式会社 非水電池用電解液及びこれを用いた非水電池
LT2229351T (lt) * 2007-12-11 2018-01-25 Newron Pharmaceuticals S.P.A. Didelio grynumo laipsnio 2-[4-(3- arba 2-fluorbenziloksi)benzilamino]propanamidų gamybos būdas
NZ586182A (en) 2007-12-19 2012-02-24 Newron Pharm Spa Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
WO2009109334A1 (en) 2008-03-07 2009-09-11 Newron Pharmaceuticals S.P.A. (s)-(+)-2-[4-fluorbenzyloxy)benzylamino]propanamide for use in the treatment of mixed or combined pain
CA2794389C (en) * 2010-04-27 2016-08-23 Newron Pharmaceuticals S.P.A. Process for the production of ralfinamide methanesulfonate salts or their r-enantiomers

Similar Documents

Publication Publication Date Title
JP2011126894A5 (enExample)
JP2013528577A5 (enExample)
EA201490616A1 (ru) Использование ацилсульфонамидов для улучшения урожайности растений
JP2012528877A5 (enExample)
JP2008507566A5 (enExample)
WO2012004396A3 (en) Process of preparing a thrombin specific inhibitor
NO20091301L (no) Nye aminopyridinderivater med aurora A selektiv inhiberende aktivitet
UA108645C2 (uk) Композиція для боротьби з хворобами рослин і її застосування
PH12022552034A1 (en) Pyridone derivative having tetrahydropyranyl methyl group
JP2013542935A5 (enExample)
MX2012013332A (es) Preparacion de intermediarios de posaconazol.
ME02054B (me) Agomelatin hidroklorid hidrat i njegova priprava
JP2016523834A5 (enExample)
MX363405B (es) Derivados de indanona, sales farmaceuticamente aceptables o isomeros opticos de los mismos, metodo de preparacion de los mismos, y composiciones farmaceuticas que contienen los mismos como ingrediente activo para prevención o tratamiento de enfermedades virales.
MD4415B1 (ro) Procedeu de preparare a formei cristaline delta a sării perindopril-L-arginină
AR081267A1 (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
ME02309B (me) Agomelatin hidrobromid hidrat i njegova priprema
JP4967659B2 (ja) L−カルニチンの精製方法
JP2011529942A5 (enExample)
RU2019106531A (ru) Кристалл соли производного хиназолина
WO2013172741A3 (ru) Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси) циклогексен-1-карбоновые кислоты, их эфиры и способ применения
NZ700221A (en) Ralfinamide methanesulfonate salts
MX355498B (es) Derivados de 1,3-dioxoindeno, sal farmaceuticamente aceptable de los mismos, metodos de preparacion de los mismos y composicion farmaceutica para el antivirus que contiene el mismo como un ingrediente activo.
RU2011143166A (ru) Новые кристаллические формы адефовира дипивоксила и способы его получения
RU2013122374A (ru) Препарат, обладающий антитоксической активностью и содержащий комплексное соединение производного метилурацила с органической кислотой, и способ его получения